Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(14%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
5
71%
Ph phase_3
1
14%
Ph phase_2
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Other(3)

Detailed Status

unknown3
Completed3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (14.3%)
Phase 31 (14.3%)
N/A5 (71.4%)

Trials by Status

unknown343%
active_not_recruiting114%
completed343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7